May 6, 2015 writer

TSO3 RECEIVES THE 2014 GRAND AWARD FOR WEALTH CREATION-QUEBEC METRO

Quebec City, May 6, 2015 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in low temperature sterilization technology for medical devices in healthcare settings, is pleased to announce that it received the 2014 Grand Award for Wealth Creation-Quebec Metro as part of the annual gala of the Quebec publicly listed companies.

“We receive this award as a recognition of the perseverance and hard work of our employees towards obtaining Food and Drug Administration clearance, while continuing to provide great service to our current customer base,” stated R.M. (Ric) Rumble, President and CEO of TSO3. “With the green light to commercialize our STERIZONE® VP4 Sterilizer in the U.S. and our new sales and service partner, the team is now undertaking a new journey to even greater wealth creation,” concluded Mr. Rumble.

About TSO3

Founded in 1998, TSO3’s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. It also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO3, visit the Company’s Web site at www.tso3.com.

The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

-30-

Back to Posts